Table of Contents
Licensing
| Novartis Pays US$150 M Upfront for Monte Rosa’s Molecular Glue Degrader | Abstract pdf html |
| Lucy Haggerty |
Mergers & Acquisitions
| AbbVie Acquires Aliada Therapeutics for US$1.4 B to Advance Alzheimer’s Research | Abstract pdf html |
| Swati Sharan |
| GSK Acquires Chimagen Biosciences’ CMG1A46 for US$300 M Upfront | Abstract pdf html |
| Shweta Gupta & Swati Sharan |
| Novartis Acquires Gene Therapy Specialist Kate Therapeutics in US$1.1 B Deal | Abstract pdf html |
| Lucy Haggerty |
This work is licensed under a Creative Commons Attribution 3.0 License.